On January 24, YP-Baltimore chapter leaders Hussain and Minzhi attended a briefing in Annapolis, MD, which was called by the Senate Finance Committee to discuss more about the pricing of prescription drugs.
Key stakeholders were present, including leaders from Pharmaceutical Research and Manufactures Association of America (PhRMA), CareFirst Blue Cross Blue Shield, Pharmaceutical Care Management Association (leader of 12 pharmaceutical benefit managers), research professors from Johns Hopkins, Institute for Clinical and Economic Review, and the Special Assistant from the Office of the Attorney General. There were four panels with two to four experts. Each expert made a brief presentation related to their perspective on prescription drug pricing and raised discussion on key challenges and recommendations.Read more
UN High-Level Panel on Access to Medicines Publishes Landmark Report Reaffirming Fundamental Right to Health
The United Nations Secretary-General's High-Level Panel on Access to Medicines released their landmark report to address the tensions between public health, international human rights law, trade rules, and the justifiable rights of inventors in the context of health technologies.Read more
The World Health Organization (WHO) recently published a discussion paper on improving accessibility, availability and affordability of essential medicines and basic health technologies for NCDs. WHO is seeking input from diverse stakeholders, in order to strengthen its technical assistance to Member States in efforts to meet the target of “80% availability of affordable basic technologies and essential medicines” for NCDs.Read more